DocSym
β
Searchsearch
Search
(Y49.4) Butyrophenone and thioxanthene neuroleptics
More details coming soon
41 630 in individuals diagnosis butyrophenone and thioxanthene neuroleptics confirmed
2 424 deaths with diagnosis butyrophenone and thioxanthene neuroleptics
6% mortality rate associated with the disease butyrophenone and thioxanthene neuroleptics
Diagnosis butyrophenone and thioxanthene neuroleptics is diagnosed Women are 41.95% more likely than Men
12 083
Men receive the diagnosis butyrophenone and thioxanthene neuroleptics
710 (5.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
29 547
Women receive the diagnosis butyrophenone and thioxanthene neuroleptics
1 714 (5.8 %)Died from this diagnosis.
Risk Group for the Disease butyrophenone and thioxanthene neuroleptics - Men aged 15-19 and Women aged 20-24
In Men diagnosis is most often set at age 5-9, 15-29, 35-54, 65-79
Less common in men the disease occurs at Age 0-5, 10-14, 30-34, 55-64, 80-95+Less common in women the disease occurs at Age 0-5, 80-84, 90-95+
In Women diagnosis is most often set at age 5-79, 85-89
Disease Features butyrophenone and thioxanthene neuroleptics
Absence or low individual and public risk
Butyrophenone and thioxanthene neuroleptics - what does this mean
Butyrophenone and thioxanthene neuroleptics are a class of antipsychotic medications that work by blocking dopamine receptors in the brain. this helps to reduce psychotic symptoms such as hallucinations, delusions, and disorganized thinking. they can also be used to treat certain types of anxiety disorders, as well as mania and aggression.
What happens during the disease - butyrophenone and thioxanthene neuroleptics
Butyrophenone and thioxanthene neuroleptics are a class of drugs that act on dopamine receptors in the brain to reduce psychotic symptoms. they are thought to work by blocking the action of dopamine in the brain, reducing the activity of the neurotransmitter and thus reducing psychotic symptoms. they can also cause side effects such as drowsiness, dry mouth, constipation, and weight gain. long-term use can also lead to changes in brain chemistry, including changes in serotonin levels, which can lead to increased risk of depression and anxiety.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Butyrophenone and thioxanthene neuroleptics - Prevention
Butyrophenone and thioxanthene neuroleptics can be prevented by avoiding exposure to certain environmental toxins, maintaining a healthy lifestyle, and getting regular check-ups and screenings. additionally, it is important to recognize the signs and symptoms of the disease and seek treatment as soon as possible.